The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Vitamin D and Kidney Disease
Open accessAbstract
Abnormalities in vitamin D metabolism play a major role in the pathogenesis of secondary hyperparathyroidism in chronic kidney disease. The gradual and progressive decline in 1,25-dihydroxyvitamin D in the course of chronic kidney disease is the result of several mechanisms that limit the ability of the failing kidney to maintain the levels of 1,25-dihydroxyvitamin D despite increasing levels of parathyroid hormone. Recent observations have indicated that chronic kidney disease seems to be associated with a high incidence of nutritional vitamin D insufficiency or deficiency as manifested by decreased levels of 25-hydroxyvitamin D. This contributes to the inability to maintain the levels of 1,25-dihydroxyvitamin D; therefore, current practice guidelines suggest repleting vitamin D status by the administration of native vitamin D as a first step in the therapy of the abnormalities of bone and mineral metabolism in chronic kidney disease. The efficacy of this therapy is extremely variable, and active vitamin D sterols may be required, especially as kidney disease progresses. The importance of the abnormal vitamin D metabolism is being investigated vigorously in view of the observations that vitamin D may have important biologic actions in many tissues in addition to bone and parathyroid. Thus, observational data have suggested potential survival benefits of vitamin D sterol administration in this clinical setting, and experimental data have suggested a potential beneficial effect of vitamin D sterols on the progression of kidney disease. Further work is required to define the mechanisms involved and to examine the effects of vitamin D therapy on outcomes in randomized, controlled trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Al-Aly, Z., Qazi, R. A., González, E. A., Zeringue, A., & Martin, K. J. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.04.010 · Cited by 156 · cited 1×
“(15) were similar in design to the studies of Zisman et al.”
ResultSelf-citation
Cited by
Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder
Fukagawa, M., Yokoyama, K., Koiwa, F., Taniguchi, M., Shoji, T., Kazama, J. J., Komaba, H., Ando, R., Kakuta, T., Fujii, H., et al. (2013) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12058 · Cited by 402
Plant-based diets to manage the risks and complications of chronic kidney disease
Carrero, J. J., González-Ortiz, A., Avesani, C. M., Bakker, S. J. L., Bellizzi, V., Chauveau, P., Clase, C. M., Cupisti, A., Espinosa-Cuevas, A., Molina, P., et al. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0297-2 · Cited by 326
Uhlig, K., Berns, J. S., Kestenbaum, B., Kumar, R., Leonard, M. B., Martin, K. J., Sprague, S. M., & Goldfarb, S. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.02.340 · Cited by 265
Self-citation
Metadata
- Authors
- Al-Badr, W., & Martin, K. J.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2008-09
- Volume
- 3
- Issue
- 5
- Pages
- 1555-1560
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2126590583
- Cited by
- 182
- References
- 1
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vitamin D and Kidney Disease. https://app.cochat.ai/papers/10.2215/cjn.01150308
- The paper
- Al-Badr, W., & Martin, K. J. (2008). Vitamin D and Kidney Disease. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.01150308
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.